Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates
Reuters
Tue, 05/7/24 - 11:12 am
Tags:
Kenvue, earnings, JNJ, consumer health, spinoffs
J&J’s ‘Pretzel’ Drug-Device Combo Scores in Mid-Stage Bladder Cancer Study
BioSpace
Mon, 05/6/24 - 05:52 pm
Tags:
JNJ, clinical trials, TAR-200, drug-device combos, bladder cancer
Johnson & Johnson reports data from Phase II prostate cancer trial
Clinical Trials Arena
Mon, 05/6/24 - 11:28 am
Tags:
JNJ, clinical trials, Erleada, prostate cancer
As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL
Fierce Pharma
Thu, 05/2/24 - 11:31 am
Tags:
AbbVie, JNJ, Imbruvica, AstraZeneca, Calquence, mantle cell lymphoma
J&J advances $6.48 billion settlement of talc cancer lawsuits
Reuters
Wed, 05/1/24 - 11:16 pm
Tags:
JNJ, talc, legal, ovarian cancer, settlements
J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate
BioSpace
Mon, 04/29/24 - 10:56 pm
Tags:
Addex Therapeutics, JNJ, ADX71149, epilepsy, clinical trials
J&J, Bristol Myers lose challenges to US drug price negotiation program
Reuters
Mon, 04/29/24 - 10:52 pm
Tags:
Bristol Myers Squibb, JNJ, Medicare, Inflation Reduction Act, legal
Orphan drug market to reach $270B by 2028, led by J&J, Vertex and Roche
Fierce Pharma
Wed, 04/24/24 - 08:50 am
Tags:
orphan drugs, Evaluate Pharma, JNJ, Vertex Pharmaceuticals, Roche
Inside J&J’s strategy to de-gender clinical trials
Pharma Voice
Tue, 04/23/24 - 10:33 am
Tags:
clinical trials, LGBTQ+, clinical trial diversity, JNJ
AbbVie tops doctor ranking of immunology companies, handily beating Pfizer and J&J
BioSpace
Mon, 04/22/24 - 11:45 am
Tags:
physicians, AbbVie, JNJ, Pfizer, immunology
‘We think in decades’: J&J’s $30B spending spree may not be over
Medtech Dive
Tue, 04/16/24 - 10:07 pm
Tags:
JNJ, Medtech, M&A, Abiomed, Laminar, Shockwave Medical
J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
BioSpace
Tue, 04/16/24 - 11:19 am
Tags:
JNJ, earnings
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Mon, 04/15/24 - 11:16 am
Tags:
Legend Biotech, Carvykti, mutliple myeloma, JNJ
J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wed, 04/10/24 - 06:01 pm
Tags:
JNJ, Rallybio, FNAIT, drug development
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Medical Marketing and Media
Fri, 04/5/24 - 11:54 am
Tags:
JNJ, M&A, Medtech, Shockwave Medical, Cardiovascular, intravascular lithotripsy
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech, M&A, IPOs, CG Oncology, Kyverna Therapeutics, Contineum Therapeutics, Boundless Bio, CymaBay Therapeutics, Gilead Sciences, MorphoSys, Novartis, Fusion Pharmaceuticals, AstraZeneca, Ambryx, JNJ, Inhibrix, Aventis
J&J targets rare maternal-fetal diseases: 'We're going for this. No one else has.'
Fierce Biotech
Tue, 04/2/24 - 11:49 am
Tags:
JNJ, rare disease, maternal-fetal diseases, FNAIT, nipocalimab
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Reuters
Mon, 04/1/24 - 12:04 pm
Tags:
Teva Pharmaceutical, JNJ, Viatris, schizophrenia, patents, Invega Sustenna
J&J can contest evidence linking its talc to cancer, US judge rules
Reuters
Thu, 03/28/24 - 11:14 am
Tags:
JNJ, legal, talc, ovarian cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.